En español
NIDA

Menu

NIDA Notes

Test paper with the word cannabis scribbled across the answer bubbles

Early, Regular Cannabis Use Linked to IQ Decline

Brain scans showing activity in cocaine-exposed and cocaine-naive people

Cognitive Deficits Due to Cocaine May Be Temporary

blurred image of a high school hallway with the words Rx Opioid Abuse

12th Graders Report Nonmedical Use of Rx Opioids

graphic showing how one's own substance use is influenced by self-control and friends' use

Ex-Inmates' Friends Key to Avoiding Drug Use

In This Section

NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.

Learn more about NIDA Notes

NIDA Notes Category Graphic

Prevention System Has Lasting Effects, Benefit Exceeds Costs (July 2012)

Towns that implemented a drug abuse prevention program called Communities That Care will see a return of $5.30 for each $1 they invested during the 5-year trial of the intervention, according to a cost-benefit analysis. The estimate is based on reductions in smoking and delinquency observed during the fourth year of the study among eighth-graders and the projected total costs of smoking, delinquency, and crime avoided over the lifetimes of study participants.

NIDA Notes Category Graphic

Training Gaps for Evidence-Based Practices (July 2012)

Ninety percent of privately funded substance abuse treatment programs in the United States offer cognitive behavioral therapy (CBT)...

NIDA Notes Category Graphic

Neuroscience Education Program Encourages Learning at All Ages (July 2012)

Eight scientists have received National Institutes of Health (NIH) grants to develop K-12 education programs that will engage young people in learning about the brain, inspire some to pursue careers in biomedical science, and increase teacher knowledge of neuroscience. The 5-year grants are funded by the NIH Blueprint for Neuroscience Research Science Education.

NIDA Notes Category Graphic

Buprenorphine During Pregnancy Reduces Neonate Distress (July 2012)

Sublingual buprenorphine is a safe and effective alternative to methadone for treating opioid dependence during pregnancy, finds the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a NIDA-supported clinical trial. Women who received either medication had similar pregnancy and birth outcomes, but infants born to women who received buprenorphine had milder symptoms of neonatal opioid withdrawal.

NIDA Notes Category Graphic

Dr. David Jentsch Receives the 2011 Waletzky Memorial Award (July 2012)

Dr. J. David Jentsch is the recipient of the 2011 Jacob P. Waletzky Memorial Award for Innovative Research in Drug Addiction and Alcoholism. Dr. Jentsch and colleagues at the University of California, Los Angeles, are studying genetic and neurochemical factors that influence individual differences in inhibitory control.

NIDA Notes Category Graphic

Investigators Map Functional Networks in the Rat Brain (June 2012)

Researchers have mapped the fundamental functional organization of the rat brain and shown that it resembles that of the human brain.

NIDA Notes Category Graphic

Elevated Rates of Drug Abuse Continue for Second Year (June 2012)

Illicit drug use in the United States in 2010 was at its highest level since 2002, according to the most recent report from the National Survey on Drug Use and Health. A rise in marijuana use drove the increase. A favorable trend of falling cocaine use continued.

NIDA Notes Category Graphic

High Rates of Job Leaving Among Addiction Counselors (April 2012)

Substance abuse counselors and clinical supervisors disclosed high job turnover rates in a survey of 27 treatment organizations.

NIDA Notes Category Graphic

Physical Activity Reduces Return to Cocaine Seeking in Animal Tests (April 2012)

Two independent animal studies suggest that aerobic exercise might help cocaine abusers establish and maintain abstinence.

NIDA Notes Category Graphic

Research Focuses on Groups With High Smoking Rates (April 2012)

Dr. Volkow discusses NIDA’s efforts to develop effective antismoking treatments for populations with persistently high rates of smoking, such as people with psychiatric disorders, high school dropouts, and Native Americans.

Pages

    Attention

    Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

    Looking for Treatment?

    Use the SAMHSA Treatment Locator or 1-800-662-HELP.

    Helpline open during government shutdown

    Subscribe to NIDA Notes

     

    An Anti-Drug Vaccine at Work

    Anti-drug Vaccine Animation

    Scientists see great promise in the idea of combining vaccines with other interventions to improve patient outcomes in addiction therapy.